Jeffrey G. Black - 25 Feb 2022 Form 4 Insider Report for Apollo Endosurgery, Inc.

Signature
/s/ Brian Szymczak - Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
25 Feb 2022
Net transactions value
+$229,100
Form type
4
Filing time
01 Mar 2022, 17:22:44 UTC
Previous filing
11 Aug 2021
Next filing
16 Jun 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APEN Common Stock Purchase $82,200 +15,000 +6.7% $5.48 240,000 25 Feb 2022 Direct F1
transaction APEN Common Stock Purchase $84,900 +15,000 +6.2% $5.66 255,000 28 Feb 2022 Direct F2
transaction APEN Common Stock Purchase $62,000 +10,000 +3.9% $6.20 265,000 01 Mar 2022 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents weighted average price of shares purchased. Prices ranged between $5.40 - $5.50, inclusive. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 Represents weighted average price of shares purchased. Prices ranged between $5.58 - $5.76, inclusive. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F3 Represents weighted average price of shares purchased. Prices ranged between $5.80 - $6.30, inclusive. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.